Total Payments
$3,046
2021 Payments
$883.84
Companies
17
Transactions
198
Medicare Patients
1,251
Medicare Billing
$187,507
Payment Breakdown by Category
Food & Beverage$3,046 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,046 | 198 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $1,477 | 57 | $0 (2021) |
| PFIZER INC. | $466.95 | 68 | $0 (2019) |
| Amgen Inc. | $174.23 | 19 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $125.49 | 8 | $0 (2021) |
| Janssen Biotech, Inc. | $125.30 | 9 | $0 (2021) |
| Horizon Pharma plc | $123.06 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $121.35 | 9 | $0 (2021) |
| MEDEXUS PHARMA, INC. | $108.94 | 5 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $107.06 | 8 | $0 (2020) |
| Lilly USA, LLC | $57.70 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $883.84 | 40 | AbbVie Inc. ($614.94) |
| 2020 | $593.23 | 25 | AbbVie Inc. ($501.48) |
| 2019 | $907.00 | 80 | AbbVie, Inc. ($297.78) |
| 2018 | $504.48 | 51 | PFIZER INC. ($285.39) |
| 2017 | $157.42 | 2 | Horizon Pharma plc ($123.06) |
All Payment Transactions
198 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/05/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.24 | General |
| Category: IMMUNOLOGY | ||||||
| 09/29/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $84.77 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2021 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Immunology | ||||||
| 08/24/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2021 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI ARIA | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: Immunology | ||||||
| 08/17/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Immunology | ||||||
| 08/12/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $75.97 | General |
| Category: IMMUNOLOGY | ||||||
| 08/11/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: IMMUNOLOGY | ||||||
| 08/11/2021 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Inflammation | ||||||
| 08/10/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: IMMUNOLOGY | ||||||
| 07/27/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Immunology | ||||||
| 07/20/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: IMMUNOLOGY | ||||||
| 07/13/2021 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Immunology | ||||||
| 07/07/2021 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $12.50 | General |
| Category: Immunology | ||||||
| 07/06/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: IMMUNOLOGY | ||||||
| 07/01/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: KRYSTEXXA | ||||||
| 06/24/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: IMMUNOLOGY | ||||||
| 06/16/2021 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Immunology | ||||||
| 05/28/2021 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 05/20/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.02 | General |
| Category: IMMUNOLOGY | ||||||
| 05/19/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: IMMUNOLOGY | ||||||
| 05/18/2021 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $13.75 | General |
| Category: Immunology | ||||||
| 05/14/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 13 | 611 | 3,246 | $179,697 | $91,730 |
| 2020 | 13 | 640 | 3,368 | $209,896 | $95,778 |
Total Patients
1,251
Total Services
6,614
Medicare Billing
$187,507
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 29 | 2,100 | $52,500 | $34,269 | 65.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 245 | 377 | $60,320 | $32,453 | 53.8% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 15 | 62 | $20,894 | $5,572 | 26.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 39 | 39 | $9,360 | $4,935 | 52.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 19 | 72 | $9,000 | $3,781 | 42.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 51 | $5,610 | $3,164 | 56.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 21 | $4,410 | $3,015 | 68.4% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 20 | 24 | $4,440 | $1,458 | 32.8% |
| 96415 | Infusion of chemotherapy into a vein | Office | 2021 | 13 | 54 | $3,240 | $1,191 | 36.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 77 | 113 | $5,537 | $1,060 | 19.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 48 | 95 | $1,710 | $639.76 | 37.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 20 | 148 | $1,776 | $146.58 | 8.3% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2021 | 25 | 90 | $900.00 | $44.50 | 4.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 21 | 1,980 | $49,500 | $30,645 | 61.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 217 | 376 | $58,280 | $29,687 | 50.9% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 29 | 165 | $55,605 | $16,239 | 29.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 62 | 62 | $14,880 | $7,294 | 49.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 58 | $6,090 | $3,281 | 53.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 17 | 17 | $3,570 | $1,880 | 52.7% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 27 | 34 | $4,920 | $1,747 | 35.5% |
| 96415 | Infusion of chemotherapy into a vein | Office | 2020 | 11 | 66 | $3,960 | $1,513 | 38.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 73 | 119 | $5,831 | $1,206 | 20.7% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2020 | 52 | 135 | $2,418 | $1,106 | 45.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 30 | 30 | $1,230 | $912.80 | 74.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 30 | 176 | $2,112 | $194.32 | 9.2% |
About Dr. Timothy Drehmer, MD
Dr. Timothy Drehmer, MD is a Rheumatology healthcare provider based in Troy, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285690024.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Drehmer, MD has received a total of $3,046 in payments from pharmaceutical and medical device companies, with $883.84 received in 2021. These payments were reported across 198 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,046).
As a Medicare-enrolled provider, Drehmer has provided services to 1,251 Medicare beneficiaries, totaling 6,614 services with total Medicare billing of $187,507. Data is available for 2 years (2020–2021), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Troy, OH
- Active Since 04/21/2006
- Last Updated 04/19/2021
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1285690024
Products in Payments
- RINVOQ (Biological) $557.99
- XELJANZ (Drug) $422.16
- RINVOQ (Drug) $387.12
- Rinvoq (Biological) $229.59
- Enbrel (Biological) $163.27
- Humira (Biological) $130.68
- ORENCIA (Biological) $125.49
- KRYSTEXXA (Drug) $123.06
- BENLYSTA (Biological) $121.35
- Rasuvo (Drug) $108.94
- COSENTYX (Biological) $107.06
- HUMIRA (Biological) $104.30
- REMICADE (Biological) $62.22
- INFLECTRA (Biological) $44.79
- TALTZ (Drug) $44.03
- KRYSTEXXA (Biological) $41.70
- TREMFYA (Drug) $40.86
- Mitigare (Drug) $30.33
- ACTHAR (Biological) $28.59
- SIMPONI ARIA (Biological) $22.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.